Get started

Niftypharma

Prebreakout Buildup at a 4-Year Resistance: IPCA LaboratoriesTL;DR: The High-Conviction "Pre-Breakout Buildup & Squeeze" Setup IPCA Labs is currently edging towards the apex of a year-long pennant consolidation at a major 4-year resistance level. With both NIFTY and NIFTY Pharma indices looking bullishly poised, the odds favor bullish breakout in IPCA soon. Step 1: The "Forest to the Trees" Filter (Tailwinds) The Forest (Nifty 50): The broad market is structurally robust, coiling near record highs and positioned for a possible continuation breakout. The Trees (Nifty Pharma Index): The NIFTY Pharma index also looks good, positioned for a possible bullish breakout. Conclusion: Macro and sector tailwinds are firmly in place to support individual pharma breakouts. Step 2: Big Picture (Stan Weinstein Stage Analysis) The 4-Year Ceiling: The stock has been capped by a major horizontal resistance at ₹1380 since 2021. The Buildup Phase: An initial breakout attempt in late 2024 failed to sustain, leading to a year-long pennant-shaped continuation pattern. This oscillation has allowed the stock to absorb the multi-year overhead supply. The Stage: Having spent significant time basing and now coiling at range highs, IPCA is primed for a transition into a decisive Stage 2 Advance. Step 3: Execution Structure (Prebreakout PA Analysis) The Buildup: The last 12 months show a tightening "pennant" structure right at the key ₹1380 level - a classic sign of institutional absorption. Momentum Signal: November 2025 saw a strong bullish monthly bar breaking above the 20-Month EMA and the resistance level on high volume. The Prebreakout Squeeze: December 2025 is closing as a tight doji above the breakout level. This narrow-spread candle above the EMA/resistance is a "squeeze" that creates tension - and could resolve in an explosive move if bulls can push beyond the year-long pattern's boundary. Step 4: Fundamental Engine (The Notebook) Operational Turnaround: Q2 FY2026 saw robust profit growth of 23.13% YoY (₹282.57 Cr) and record quarterly revenue. Margin Expansion: Standalone EBITDA margins surged to 25.46%, a 257 bps improvement reflecting enhanced operational efficiency. API Surge: The API business is a major growth driver, with sales increasing 28% to ₹408 Cr in the most recent quarter. Valuation Gap: Currently trading at a P/B of ~4.9x. While higher than some peers, its ROA of ~7.3% and ROE of ~12.8% are trending upward as operational leverage kicks in. Financial Health: Maintains a very low debt-to-equity ratio of ~0.19 with an interest coverage ratio of 34.9x. Possible Entries: Aggressive: Within the current "squeeze" zone (₹1380–₹1470), as close to the 20-Month, or 20-Week EMA as possible. Important note for this entry - check how the monthly closes (in 2 days from now). If it closes somewhat like it looks now (a tight doji), then this entry would have decent odds. Conservative: On a decisive weekly close above the pennant's upper boundary. Invalidation of the setup: Bearish break & close below the pennant, or below the 20-month EMA (or 20-week EMA if following on weekly) Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Market investments are subject to risk; please consult a SEBI-registered advisor before trading.
NSE:IPCALABLong
by traderoogway
Pharma Index looking good in the long run. Nifty Pharma Index seems to be breaking out on the Weekly chart. It has formed a head and shoulder kind of structure in addition to this it seems to be on the verge of a trend line breakout. RSI index also seems to be becoming bullish. Currently Pharma index closed the week at 22821. A closing in this index above 22829 can take it forward towards next resistances which are at 23076 and 23561. A weekly closing above 23561 will make the index more Bullish and can send it into frenzy towards 23810 or eve 24193 or higher. Support for Pharma index currently is near 22200, 21712 (Mother line support) and 21385. Shadow of the candle is turning more positive. When the index is strong and gives a breakout it means that the undercurrent in majority of the companies which constitute the index is strong. There will be some companies which will obviously drag the index down as there cannot be one-way traffic. To know amongst these which companies to invest in an investor should look at fundamentals of the company, recent and past results, cash flows, Sales and order books, EPS and many other factors. While a Technical investor should look at charts of the companies before investing. Nifty Pharma index consists of 20 companies. The companies that constitute this index are Abbott, Ajanta Pharma, Alkem, Aurobindo Pharma, Biocon, Cipla, Divi’s Lab, Dr Reddy, Gland Pharma Glenmark Pharma, IPCA Labs, JB Chem Pharma, Laurus Labs, Lupin, Mankind Pharma, Piramal Pharma, Sun Pharma, Torrent Pharma, Wockhardt and Zydus Life Sciences. Amongst these companies look for strong performers within this index who have given a good result this quarter and have strong EPS growth and good order books as well as trailing PE ratio less than 10 years Average PE ratio. This would result in you finding out the companies which are undervalued and have good growth potential. Capital Goods are essential for a country to grow. A strong GDP will mostly mean strong performance by some these companies. A smart investor would be a person who looks at both fundamentals and technicals of the company and invests in a fundamentally strong company which is giving a technical breakout. For this one has to learn Techno-Funda analysis. I have written a book on the subject called The Happy Candles Way To Wealth Creation. In this book you will learn the basics of Techno-Funda investing. The book is available on Amazon and is one of the highest rated books in its category. With an approval rating of 4.8/5 as on date. Lot of investors call it as a Hand book for Techno Funda investing. Most of the chapters are standalone and can be read at your own accord. It will be really helpful to you. To know more about Mother line, Father line and my Mother, Father and Small child theory, Parallel Channel you should once again I recommend, read my book the Happy Candles Way to Wealth Creation. Disclaimer: The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock or index. The Techno-Funda analysis is based on data that is more than 3 months old. Supports and Resistances are determined by historic past peaks and Valley in the chart. Many other indicators and patterns like EMA, RSI, MACD, Volumes, Fibonacci, parallel channel etc. use historic data which is 3 months or older cyclical points. There is no guarantee they will work in future as markets are highly volatile and swings in prices are also due to macro and micro factors based on actions taken by the company as well as region and global events. Equity investment is subject to risks. I or my clients or family members might have positions in the stocks that we mention in our educational posts. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message. Do consult your investment advisor before taking any financial decisions. Stop losses should be an important part of any investment in equity.
NSE:CNXPHARMA
by Happy_Candles_Investment
Index To Watch Next Week: CNX Pharma Index. The index that did very well this week and which has potential to carry forward the momentum into the next week seems to be the CNX Pharma Index. The pharma index looks strongly placed above Mother Line of 50 Weeks EMA line. The resistances it faces or can face if it moves upwards can be near 21667. If this trend line resistance is crossed, there is a possibility of Pharma index reaching 22117 or 22428 . 22428 will be a little tough to cross as it is the mid resistance of the parallel channel in which CNX Pharma index is travelling. If we get a closing above it, there is a real possibility for the index to reach 22715 or even 23K+ levels. The support for CNX Finance is the Mother and Father lines which are merged near 21144 and 21176 zone. If this major support zone is broken the index may fall to 20637 or 19628 levels. To know more about Parallel Channels, Mother, Father and small Child Theory, Behavioural finance, Fundamental analysis, Technical analysis, Profit booking etc. Read my book The Happy Candles Way to Wealth creation. It is as on date one of the highest rated books on Amazon. The paperback version and Kindle can be bought through Amazon. You can also contact me to buy the same. Now if this breakout actually happens in the Nifty Pharma index the some of the stocks that composites the Pharma Finance will be the beneficiaries. Some might benefit more some might benefit less and some might not benefit but for index to move upward the stocks composing it have to perform well. To know which stocks will do better than others we will have to look at their individual charts. The stocks which make the Nifty Pharma index are Sun Pharma, Mankind Pharma, Dr Reddy’s Lab, Auro Pharma, Lupin, Cipla, Glenmark, Ajanta Pharma, Biocon, Alkem, Laurus Labs, JB Chem Pharma, Granules, IPCA Labs, Abbott, Zydus Life, Natco Pharma, Gland Pharma, Torrent Pharma, Divi’s Lab. The Index Can Perform if the majority constituents or the stocks with heavy weightage perform. Some of these stocks can perform others might not. Choose wisely after consulting your investment advisor, studying fundamentals and Technicals of each company. Disclaimer: The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. No one can guarantee any success in highly volatile market or otherwise. There is also chance of bias in our opinion. The supports and resistances indicated are based on data which has a cycle time of being 3 months or older so it is not necessary that it will work. The author or Smart Investment will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:CNXPHARMALong
by Happy_Candles_Investment
Momentum Trading Picks - Pharma Stock Natco Pharma.This chart is very interesting as well as confusing at the same time for some people let's break it down step by step. If you see the monthly chart of Natco Pharma you will notice many patterns there like:- Cup pattern W pattern Pole and flag Pattern Volume is increasing significantly on the monthly chart Breakout already happened last week but those who are willing to take risks can still participate in it because the stop loss will be a bit on the higher side.
NSE:NATCOPHARMLong
by mittalanugrahit
SOLARA ACTIVE PHARMA LONG TERM VIEWSolara Active Pharma is forming a rounding bottom formation or W pattern on Monthly TimeFrame. The Entry and Stoploss would be considered on Candle Closing Basis. Entry - Above 470 Stoploss - Below 273 Target - 1509 ( This Target would be achieved in 2 years max from the date of entry). NOTE:- This view is purely based on Technical Analysis and is for educational purposes only. Please consult your financial advisor before taking any trade
NSE:SOLARALong
by joukaniram
Unlocking Profit Potential: TORNTPHARM Analysis 🚀In the thrilling world of trading, decoding charts can be as exciting as a rollercoaster ride. Buckle up, we're about to unravel the secrets of TORNTPHARM. 📊 Current Positioning of TORNTPHARM Currently, TORNTPHARM is perched near the 75-minute zone (LTF). On the intermediate timeframe (ITF), it basks in the daily demand zone, close to the daily 20EMA, with an upward trend. Zooming out to the higher timeframe (HTF), the weekly chart reveals it's in a weekly demand zone after reaching all-time highs. The 75-minute demand zone is of the RBR type – Rally Base Rally. Plan your entry just above this zone, set the stop loss below, and target the 75-minute supply zone. The risk-to-reward ratio is an impressive 1:5. 🔍 Interpreting the Time Frames LTF (Lower Time Frame): Timeframe for executing trades. ITF (Intermediate Time Frame): Where we identify the overall trend. HTF (Higher Time Frame): Timeframe for location analysis. Lastly, remember, this analysis is for educational purposes only, and I am not a SEBI registered analyst
NSE:TORNTPHARMLong
by AfnanTAjuddin
ASTER DM HEALTHCARE LTD - Ascending Triangle Breakout📊 Script: ASTERDM (ASTER DM HEALTHCARE LIMITED) 📊 Nifty50 Stock: NO 📊 Sectoral Index: NIFTY 500 / NIFTY SMALLCAP / NIFTY PHARMA 📊 Sector: Healthcare 📊 Industry: Healthcare Services - Hospital Key highlights: 💡⚡ 📈 Script is trading at upper band of Bollinger Bands (BB) and giving breakout of it. 📈 MACD is giving crossover. 📈 Double Moving Averages also giving crossover. 📈 Volume is increasing along with price which is volume breakout. 📈 Script is giving breakout of Ascending Triangle. 📈 Current RSI is around 65. 📈 One can go for Swing Trade. ⏱️ C.M.P 📑💰- 265.55 🟢 Target 🎯🏆 - 304 ⚠️ Stoploss ☠️🚫 - 247 ⚠️ Important: Always maintain your Risk & Reward Ratio. ⚠️ Purely technical based pick. ✅Like and follow to never miss a new idea!✅ Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes. Eat🍜 Sleep😴 TradingView📈 Repeat🔁 Happy learning with trading. Cheers!🥂
NSE:ASTERDMLong
by radha_23
1
ALEMBIC LTD Weekly Double BottomAlembic Ltd has formed a double Bottom on weekly chart, Enter with little qty @ CMP and add on dips for the retest. Safe Buyers can wait for retest of the neckline and enter after confirmation. Please give a boost if you like the analysis and follow for more. Any suggestions or advice is humbly welcomed. Disclaimer:I am not a SEBI Registered Analyst, and the views expressed here are solely my own and for educational purposes only. Make sure you consult your Financial advisor before investing, as I won't be responsible for any losses incurred.
NSE:ALEMBICLTDLong
by Kaushik_Karnale
Pharma Alert.! Another rally or Trap.?NSE:CNXPHARMA According to my analysis this breakout in the nifty pharma sector can give a rally upto 11% in coming months which will overall help the pharma stocks to boost and bring back them in this market where evryone is underestimating the power of pharma sector in the long run. but this is how ever a short term view on the pharma sector. what is the mid term view on pharma sector?, it shows me that higher levels will be tested and there can be a fall in the name of recession period to the level of 7000's. all the best i hope it was helpfull.
NSE:CNXPHARMALong
by IG_TRADER
DR. LAL PATH LABS LTD - Multiple Indicators + Just a View 📊 Script: LALPATHLAB (DR. LAL PATH LABS LTD.) 📊 Nifty50 Stock: NO 📊 Sectoral Index: NIFTY PHARMA / NIFTY500 / NIFTY MIDCAP 📊 Sector: Healthcare 📊 Industry: Healthcare Service Provider Key highlights: 💡⚡ 📈 Script is trading at upper band of Bollinger Bands (BB) and it may give breakout of it. 📈 MACD is giving crossover. 📈 Double Moving Averages may also give crossover. 📈 Volume is increasing along with price. 📈 Current RSI is around 61. 📈 One can go for Swing Trade. ⏱️ C.M.P 📑💰- 2567 🟢 Target 🎯🏆 - 2849 ⚠️ Stoploss ☠️🚫 - 2401 ⚠️ Important: Always maintain your Risk & Reward Ratio. ✅Like and follow to never miss a new idea!✅ Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes. Eat🍜 Sleep😴 TradingView📈 Repeat 🔁 Happy Navaratri 🕉️ 💃🏻🕺🏻 Happy learning with trading. Cheers!🥂
NSE:LALPATHLABLong
by radha_23
SUPRIYA LIFESCIENCE, LEVELS!!supriya lifescience is a good company, with a good fundamentals and increasing profits. lastly it has a good profit margin too. pharma sector is a most toughest sector to analyse. still with a help of technicals and price action we can make it easier. targets are mentioned, the stock is following certaining support levels, no movement in the stock for certain continuous days, let see for a movement, and then take the trades. top of that nifty pharma will get its impulse move soon. (check links part) note: not a gurrantee investment idea, just ofr nalysis part and education part.
NSE:SUPRIYALong
by raghavchoudhary2016